6.96
price down icon7.81%   -0.59
after-market アフターアワーズ: 6.96
loading
前日終値:
$7.55
開ける:
$6.68
24時間の取引高:
348.62K
Relative Volume:
2.33
時価総額:
$145.42M
収益:
-
当期純損益:
$-22.38M
株価収益率:
-4.9362
EPS:
-1.41
ネットキャッシュフロー:
$-15.54M
1週間 パフォーマンス:
-9.96%
1か月 パフォーマンス:
-6.83%
6か月 パフォーマンス:
+2.96%
1年 パフォーマンス:
+9.61%
1日の値動き範囲:
Value
$6.3039
$7.16
1週間の範囲:
Value
$6.3039
$7.95
52週間の値動き範囲:
Value
$4.44
$11.80

Nuvectis Pharma Inc Stock (NVCT) Company Profile

Name
名前
Nuvectis Pharma Inc
Name
セクター
Healthcare (1161)
Name
電話
360-837-7232
Name
住所
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-08-07
Name
最新のSEC提出書
Name
NVCT's Discussions on Twitter

NVCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NVCT
Nuvectis Pharma Inc
6.96 157.75M 0 -22.38M -15.54M -1.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.87 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.46 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
392.24 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
670.33 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
301.13 32.46B 3.81B -644.79M -669.77M -6.24

Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 開始されました Maxim Group Buy
2025-03-17 開始されました Laidlaw Buy
2022-07-13 開始されました Ladenburg Thalmann Buy

Nuvectis Pharma Inc (NVCT) 最新ニュース

pulisher
Jul 31, 2025

Prime Medicine is selling $125M in stock; Nuvectis stops work on ovarian cancer drug - Endpoints News

Jul 31, 2025
pulisher
Jul 31, 2025

Is Nuvectis Pharma Inc. a growth stock or a value stockExpert Picks Review With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Nuvectis Pharma Plunges 15.1% on NXP800 Halt - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Nuvectis halts NXP800 development for ovarian cancer, shifts focus By Investing.com - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

Nuvectis Pharma Provides Final Clinical Data Update from - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

Key resistance and support levels for Nuvectis Pharma Inc.Free Fast Gaining Stock Screener Report - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Using R and stats models for Nuvectis Pharma Inc. forecastingSmart Trade Mapping with Entry Details - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Is it time to cut losses on Nuvectis Pharma Inc.Earnings Report Summary with Market Impact - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What makes Nuvectis Pharma Inc. stock price move sharplyInvestment Position Summary with Timeframe Forecast - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Exit strategy if you’re trapped in Nuvectis Pharma Inc.Asset Safety Selection Using Quantitative Analysis - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

How to read the order book for Nuvectis Pharma Inc.Momentum Entry Alerts with Risk Control - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Why Nuvectis Pharma Inc. stock attracts strong analyst attentionSmart Risk Strategy with Entry Optimization - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Real time scanner hits for Nuvectis Pharma Inc. explainedFree Quick Gain Stock Watch With Indicators - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Will Nuvectis Pharma Inc. benefit from macro trendsFree Fundamental Winners With Safe Entry Plan - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Volume spikes in Nuvectis Pharma Inc. stock – what they meanControlled Entry Strategy With Safety Analytics - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Nuvectis Pharma Inc. Volume Confirms Breakout — Analysts BullishTrade Setups With Clear Risk Limits Highlighted - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 06:16:31 - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How strong is Nuvectis Pharma Inc. company’s balance sheetStock Market Picks With High Returns - jammulinksnews.com

Jul 29, 2025
pulisher
Jul 28, 2025

Why is Nuvectis Pharma Inc. stock attracting strong analyst attentionMarket-beating performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Exit strategy if you’re trapped in Nuvectis Pharma Inc. Stable Profit Zone and Loss Control Analysis - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Real time scanner hits for Nuvectis Pharma Inc. explained Top Stock Picks with Forecast Accuracy - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Nuvectis Pharma Inc. stockEarnings Report Ideas With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Nuvectis Pharma Inc. stock perform well during market downturnsGrow your portfolio with growth-oriented stocks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Nuvectis Pharma Inc. company’s growth strategyCapitalize on market trends with confidence - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Nuvectis Pharma Inc. stockExplosive earnings growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Nuvectis Pharma Inc. stock expected to show significant growthPowerful market insights - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Nuvectis Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingChart Breakout Alert - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Why Nuvectis Pharma Inc. stock is on top investor watchlistsSkyrocketing investment returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Nuvectis Pharma Inc. Stock Analysis and ForecastSuperior returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Nuvectis Pharma Inc. stockUnstoppable profit momentum - PrintWeekIndia

Jul 24, 2025

Nuvectis Pharma Inc (NVCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$74.89
price down icon 3.43%
$36.80
price down icon 0.86%
$107.28
price up icon 2.00%
$26.37
price down icon 1.09%
$107.50
price down icon 2.32%
biotechnology ONC
$301.13
price up icon 0.40%
大文字化:     |  ボリューム (24 時間):